Myasthenia Gravis, also known as autoimmune myasthenia gravis, is related to neonatal myasthenia gravis and myasthenic syndrome, congenital, 6, presynaptic, and has symptoms including ptosis, diplopia and dysphagia. An important gene associated with Myasthenia Gravis is CHRNA1 (Cholinergic Receptor Nicotinic Alpha 1 Subunit), and among its related pathways/superpathways are MIF Mediated Glucocorticoid Regulation and TGF-Beta Pathway. The drugs Azathioprine and Salbutamol have been mentioned in the context of this disorder. Affiliated tissues include thymus and eye, and related phenotypes are muscle weakness and ptosis